selank australia
36 Inquiries
129954-34-3
Pharmaceutical Grade
99.99%
CHINA
Honour
customized
2024-02-12
Semaglutide,Tirzepatide,API,Enzyme
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSelank is a synthetic derivative of the tetrapeptide tuftsin that contains a proline-glycine-proline sequence at the C-terminus and has anxiolytic and anti-inflammatory activities. It increases the amplitude and discharge rate of inhibitory postsynaptic currents of neurons in the rat hippocampal CA1 region when used at a concentration of 1 μM. It decreases the level of affective responses and the number of erroneous escape attempts in rats in an acute stress situation, increases orientational-investigative responses of rats in an unfamiliar situation, and reduces the time mice spend immobile in the forced swim test. It increases locomotor activity of high-anxiety Balb/c, but not C57Bl/6, mice in the open field test. Selank (0.01 mg/kg) decreases verticalization induced by apomorphine in mice. It also decreases expression of the inflammation-related genesIl2rgandXcr1in mouse spleen after 90 minutes when administered at a dose of 100 μg/kg.
SELANK Synthetic is a single, non-glycosylated polypeptide chain containing 7 amino acids, having a molecular mass of 751.89 Dalton and a Molecular formula of C33H57N11O9.Research & Reference Noteselank australia is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
Selank peptide
Other Name:Selank peptide;SelankAcetate;PL14736;L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-proline;L-THREONYL-L-LYSYL-L-PROLYL-L-ARGINYL-L-PROLYLGLYCYL-L-PROLINE; MONOACETATE;H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH;SLANK;Selank peptid
CAS No.:129954-34-3
Molecular Formula:C33H57N11O9
InChIKeys:JTDTXGMXNXBGBZ-YVHUGQOKSA-N
Molecular Weight:751.87
Exact Mass:751.43407244
EC Number:232-660-2
UNII:TS9JR8EP1G
Categories:
Characteristics-
Density:
1.53±0.1 g/cm3(Predicted)
Melting Point:134-136 °C
PKA:3.43±0.20(Predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide,Tirzepatide,API,Enzyme
-
Location:
Unit ST-308, No. 329, Jiahe Road, Siming District, Xiamen
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
11-50
-
Year of Establishment:
2018
-
-
Inquiry History36 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Selank 99% Purity 129954-34-3
1 G Jan 23, 2026
United States
Selank peptide
10 MG Sep 18, 2026 
Greece
selank
10 MG May 20, 2026
United States
N acetyl selank
500 MG Apr 30, 2026
United States
Selank
100 MG Apr 24, 2026 
Italy
Nacetyl selank
1 MT Apr 22, 2026 
Oman
Selank
1 G Mar 4, 2026
United States
Selank
30 40' Fcl Oct 14, 2025
United States
selank
30 MG May 25, 2026 
Brazil
Selank
10 MT Apr 7, 2026
United States
selank
1 G Mar 13, 2026
United States
Selank
1 G Mar 9, 2026 
United Kingdom
Selank
1 G Dec 22, 2025
United States
Selank
20 MG Nov 10, 2025
United States
NA-Selank Amidate
10 MG Sep 18, 2025
United Kingdom
Selank
100 MG Jul 15, 2025
United States
N-Acetyl Selank Amidate
1 KG Jan 9, 2025
United States
Selank
10 Mar 29, 2024 
Poland
Selank
10 G Feb 18, 2024
United States
Selank
1 G Jan 27, 2024 Post an enquiry for this product
More from this Seller
-
-
![More than 15 years GMP Factory Suppy 99.5% 2,3,4-Trihydroxybenzaldehyde Medical Grade CAS2144-08-3]( "More than 15 years GMP Factory Suppy 99.5% 2,3,4-Trihydroxybenzaldehyde Medical Grade CAS2144-08-3")
-
More than 15 years GMP Factory Suppy 99.5% 2,3,4-Trihydroxybenzaldehyde Medical Grade CAS2144-08-3
Pharmaceutical Grade / 99.5%
-
-
-
![Zatolmilast, BPN14770 CAS 1606974-33-7]( "Zatolmilast, BPN14770 CAS 1606974-33-7")
-
Zatolmilast, BPN14770 CAS 1606974-33-7
Pharmaceutical Grade / 98%
-
-
-
![More than 15 years GMP Factory Suppy 99.5% DL-Aspartic acid hemimagnesium salt Medical Grade CAS1187-91-3]( "More than 15 years GMP Factory Suppy 99.5% DL-Aspartic acid hemimagnesium salt Medical Grade CAS1187-91-3")
-
More than 15 years GMP Factory Suppy 99.5% DL-Aspartic acid hemimagnesium salt Medical Grade CAS1187-91-3
Pharmaceutical Grade / 99.5%
-
-
-
![Cerebrolysin; FPE 1070; CAS 12656-61-0]( "Cerebrolysin; FPE 1070; CAS 12656-61-0")
-
Cerebrolysin; FPE 1070; CAS 12656-61-0
Pharmaceutical Grade / 99.99%
-
